Tilray Expands UK Footprint Through Strategic Pharma Alliance

Tilray US88688T1007

Tilray Brands is broadening its European exposure by forging a new distribution-focused partnership in the United Kingdom. The deal centers on CC Pharma, Tilray?s subsidiary, joining forces with Smartway Pharmaceuticals to strengthen the UK market?s distribution channels for medical devices and related products. The collaboration was announced on February 12, 2026, and builds on a longstanding joint history between CC Pharma and Smartway that stretches back to 2009.

• Partnership framework: CC Pharma and Smartway Pharmaceuticals
• Target market: UK-based parallel imports and specialized medical supplies
• Market size objective: roughly @ boerse-global.de | US88688T1007 TILRAY